Literature DB >> 3093014

Prostate cancer: an update.

R P Huben, G P Murphy.   

Abstract

As noted at the beginning, a discussion of prostate cancer yields as many questions as answers. Yet, as this review has suggested, major advances in our understanding of the nature and treatment of prostate cancer have been made in recent years. As more unified and rational approaches to treatment emerge, some of the marked diversity in attitudes toward prostate cancer may lessen, and the controversies about management that characterize our present state of knowledge may abate. Carefully designed studies involving larger numbers of accurately staged and stratified patients are necessary to determine preferred treatment approaches for a disease that has such a tremendous impact on the health and well-being of so many.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093014     DOI: 10.3322/canjclin.36.5.274

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  3 in total

1.  Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow.

Authors:  M Chackal-Roy; C Niemeyer; M Moore; B R Zetter
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

2.  Histologic grading of prostatic adenocarcinoma: intraobserver reproducibility of the Mostofi, Gleason and Böcking grading systems.

Authors:  M L Cintra; A Billis
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

3.  Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis.

Authors:  Juanyi Shi; Cheng Liu; Changhao Chen; Kaixuan Guo; Zhuang Tang; Yuming Luo; Luping Chen; Yinjie Su; Kewei Xu
Journal:  Aging (Albany NY)       Date:  2020-07-09       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.